Secondary Outcome(s)
|
Change in the health status of the total population measured by quality of life questionnaire Visual Function Questionnaire (VFQ)-25
[Time Frame: Screening visit (day -28 - 0) and end-of-study visit (day 360 +/- 7)]
|
Change in sub- and intraretinal und subpigmentepithelial fluids assessed using optical coherence tomography (OCT)
[Time Frame: Screening visit (day -28 - 0) and end-of-study visit (day 360 +/- 7)]
|
Change in chorioretinal neovascularization and leakage measured by angiography between end-of study visit and screening visit
[Time Frame: Screening visit (day -28 - 0) and end-of-study visit (day 360 +/- 7)]
|
Change in light increment sensitivity of central visual field between end-of study visit and screening visit measured by microperimetry
[Time Frame: Screening visit (day -28 - 0) and end-of-study visit (day 360 +/- 7)]
|
Extent of fibrovascular proliferation on optical coherence tomography (OCT) imaging
[Time Frame: Screening visit (day -28 - 0) and end-of-study visit (day 360 +/- 7)]
|
Changes fundus autofluorescence images using a confocal scanning laser ophthalmoscope (cSLO)
[Time Frame: Screening visit (day -28 - 0) and end-of-study visit (day 360 +/- 7)]
|
Occurence of Adverse Events (AEs) and Serious Adverse Events (SAEs)
[Time Frame: 12 months]
|